The effect of melatonin supplementation on liver indices in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials

Al-Dayyat, 2018, Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors, Diabetes Metab Syndr, 10.1016/j.dsx.2018.03.016 Celinski, 2014, Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease–14 months follow up, J Physiol Pharmacol, 65, 75 Allen, 2018, Healthcare cost and utilization in nonalcoholic fatty liver disease: real-world data from a large US claims database, Hepatology, 10.1002/hep.30094 Mortezaee, 2018, Melatonin application in targeting oxidative-induced liver injuries: A review, J Cell Physiol, 233, 4015, 10.1002/jcp.26209 Sumida, 2013, Involvement of free radicals and oxidative stress in NAFLD/NASH, Free Radic Res, 47, 869, 10.3109/10715762.2013.837577 Amaral, 2018, A brief review about melatonin, a pineal hormone, Arch Endocrinol Metab, 62, 472, 10.20945/2359-3997000000066 Loloei, 2019, The effect of melatonin supplementation on lipid profile and anthropometric indices: a systematic review and meta-analysis of clinical trials, Diabetes Metab Syndr: Clin Res Rev, 10.1016/j.dsx.2019.04.043 Canbakan, 2007, Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease, Acta Gastroenterol Belg, 70, 277 Mohammadi-Sartang, 2018, Effects of melatonin supplementation on blood lipid concentrations: a systematic review and meta-analysis of randomized controlled trials, Clin Nutr, 37, 1943, 10.1016/j.clnu.2017.11.003 Sun, 2015, Melatonin: a potential intervention for hepatic steatosis, Lipids Health Dis, 14, 75, 10.1186/s12944-015-0081-7 Farhan, 2018, Evaluation of melatonin hormone and nitric oxide levels in non-alcoholic fatty liver patients in relation to obesity and oxidative stress, J Pharm Sci Res, 10, 1167 Kireev, 2008, Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage, J Pineal Res, 45, 394, 10.1111/j.1600-079X.2008.00606.x Cichoz-Lach, 2010, The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis, J Physiol Pharmacol, 61, 577 Gonciarz, 2013, Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin, J Pineal Res, 54, 154, 10.1111/j.1600-079X.2012.01023.x Gonciarz, 2012, The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study, J Physiol Pharmacol, 63, 35 Khajeh Jahromi, 2017 Pakravan, 2017, The effects of melatonin in patients with nonalcoholic fatty liver disease: a randomized controlled trial, Adv Biomed Res, 6, 40, 10.4103/2277-9175.204593 Moher, 2010, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Int J Surg, 8, 336, 10.1016/j.ijsu.2010.02.007 Higgins, 2011, vol. 4 Asadi, 2019, The effect of l-carnitine supplementation on lipid profile and glycaemic control in adults with cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled clinical trials, Clin Nutr Bahrami, 2019 Sato, 2020, Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies, J Pineal Res, e12639, 10.1111/jpi.12639 Tan, 2016, Melatonin: a mitochondrial targeting molecule involving mitochondrial protection and dynamics, Int J Mol Sci, 17, 10.3390/ijms17122124 Zhou, 2018, Effects of melatonin on fatty liver disease: The role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy, J Pineal Res, 64, 10.1111/jpi.12450 Reiter, 2018, Melatonin mitigates mitochondrial meltdown: Interactions with SIRT3, Int J Mol Sci, 19, 10.3390/ijms19082439